Literature DB >> 23228441

[Adipokines in healthy and obese children].

G A Martos-Moreno1, J J Kopchick, J Argente.   

Abstract

The worldwide increase in the prevalence of obesity in children and adolescents during the last decades, as well as the mounting evidence indicating that obesity is associated with an increased incidence of comorbidities and the risk of premature death, resulting in a high economic impact, has stimulated obesity focused research. These studies have highlighted the prominent endocrine activity of adipose tissue, which is exerted through the synthesis and secretion of a wide variety of peptides and cytokines, called adipokines. This review presents a summary of the current knowledge and most relevant studies of adipokine dynamics and actions in children, focusing on the control of energy homeostasis, metabolic regulation (particularly carbohydrate metabolism), and inflammation. The particularities of adipose secretion and actions in healthy children, from birth to adolescence, and the modifications induced by early onset obesity are highlighted.
Copyright © 2012 Asociación Española de Pediatría. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23228441      PMCID: PMC4307602          DOI: 10.1016/j.anpedi.2012.10.008

Source DB:  PubMed          Journal:  An Pediatr (Barc)        ISSN: 1695-4033            Impact factor:   1.500


  154 in total

1.  Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons.

Authors:  T M Hahn; J F Breininger; D G Baskin; M W Schwartz
Journal:  Nat Neurosci       Date:  1998-08       Impact factor: 24.884

2.  The relationship between serum visfatin, adiponectin, and insulin sensitivity markers in neonates after birth.

Authors:  Cihan Meral; Ferhat Cekmez; Ozgur Pirgon; Ilhan Asya Tanju; Osman Metin Ipcioglu; Ferhan Karademir; Ismail Gocmen
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-21

3.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.

Authors:  Y Arita; S Kihara; N Ouchi; M Takahashi; K Maeda; J Miyagawa; K Hotta; I Shimomura; T Nakamura; K Miyaoka; H Kuriyama; M Nishida; S Yamashita; K Okubo; K Matsubara; M Muraguchi; Y Ohmoto; T Funahashi; Y Matsuzawa
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

Review 4.  Omentin: a novel link between inflammation, diabesity, and cardiovascular disease.

Authors:  Bee K Tan; Raghu Adya; Harpal S Randeva
Journal:  Trends Cardiovasc Med       Date:  2010-07       Impact factor: 6.677

Review 5.  Brain adipocytokine action and metabolic regulation.

Authors:  Rexford S Ahima; Yong Qi; Neel S Singhal; Malaka B Jackson; Philipp E Scherer
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

6.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

Review 7.  Endocrine and nutritional regulation of fetal adipose tissue development.

Authors:  M E Symonds; A Mostyn; S Pearce; H Budge; T Stephenson
Journal:  J Endocrinol       Date:  2003-12       Impact factor: 4.286

Review 8.  Adiponectin in childhood.

Authors:  Alison N Jeffery; Michael J Murphy; Brad S Metcalf; Joanne Hosking; Linda D Voss; Patrick English; Naveed Sattar; Terence J Wilkin
Journal:  Int J Pediatr Obes       Date:  2008

9.  Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance.

Authors:  Juan-Pablo del Rincon; Keiji Iida; Bruce D Gaylinn; Carrie E McCurdy; J Wayne Leitner; Linda A Barbour; John J Kopchick; Jacob E Friedman; Boris Draznin; Michael O Thorner
Journal:  Diabetes       Date:  2007-03-15       Impact factor: 9.461

10.  Childhood obesity, hypertension, the metabolic syndrome and adult cardiovascular disease.

Authors:  Lawrence Beilin; Rae-Chi Huang
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-04       Impact factor: 2.557

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.